NCT01608711View on ClinicalTrials.gov

A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002

PHASE2CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

August 7, 2012

Primary Completion Date

November 16, 2015

Study Completion Date

November 16, 2015

Conditions
Pancreatic CancerCarcinoma, Pancreatic DuctalPancreatic Disease
Interventions
BIOLOGICAL

AGS-1C4D4

Intravenous Infusion

BIOLOGICAL

gemcitabine

Intravenous Infusion

Trial Locations (2)

53226

Site US116, Madison

M4N 3M5

Site CA00203, Toronto

Sponsors

Lead Sponsor

Agensys, Inc.
All Listed Sponsors
lead

Agensys, Inc.

INDUSTRY

NCT01608711 - A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002 | Biotech Hunter | Biotech Hunter